Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2113090rdf:typepubmed:Citationlld:pubmed
pubmed-article:2113090lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2113090lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:2113090lifeskim:mentionsumls-concept:C0450127lld:lifeskim
pubmed-article:2113090lifeskim:mentionsumls-concept:C0039482lld:lifeskim
pubmed-article:2113090lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:2113090lifeskim:mentionsumls-concept:C0085379lld:lifeskim
pubmed-article:2113090lifeskim:mentionsumls-concept:C0108779lld:lifeskim
pubmed-article:2113090lifeskim:mentionsumls-concept:C0035015lld:lifeskim
pubmed-article:2113090lifeskim:mentionsumls-concept:C0333513lld:lifeskim
pubmed-article:2113090lifeskim:mentionsumls-concept:C1882923lld:lifeskim
pubmed-article:2113090lifeskim:mentionsumls-concept:C1548437lld:lifeskim
pubmed-article:2113090lifeskim:mentionsumls-concept:C1522701lld:lifeskim
pubmed-article:2113090lifeskim:mentionsumls-concept:C0205269lld:lifeskim
pubmed-article:2113090lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:2113090pubmed:issue3 Pt 1lld:pubmed
pubmed-article:2113090pubmed:dateCreated1990-7-20lld:pubmed
pubmed-article:2113090pubmed:abstractTextThe murine monoclonal CD3 antibody (OKT3) is effective in the treatment of refractory renal and cardiac allograft rejection and holds promise for improving rejection prophylaxis in heart transplantation. Although the administration of OKT3 is associated with many side effects, arteritis has not been previously reported. We report the development of acute necrotizing temporal arteritis associated with the deposition of mouse immunoglobulin G in a heart transplant recipient receiving OKT3 treatment of refractory rejection.lld:pubmed
pubmed-article:2113090pubmed:languageenglld:pubmed
pubmed-article:2113090pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2113090pubmed:citationSubsetIMlld:pubmed
pubmed-article:2113090pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2113090pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2113090pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2113090pubmed:statusMEDLINElld:pubmed
pubmed-article:2113090pubmed:issn0887-2570lld:pubmed
pubmed-article:2113090pubmed:authorpubmed-author:BristowM RMRlld:pubmed
pubmed-article:2113090pubmed:authorpubmed-author:DotyD BDBlld:pubmed
pubmed-article:2113090pubmed:authorpubmed-author:GilbertE MEMlld:pubmed
pubmed-article:2113090pubmed:authorpubmed-author:O'ConnellJ...lld:pubmed
pubmed-article:2113090pubmed:authorpubmed-author:RenlundD GDGlld:pubmed
pubmed-article:2113090pubmed:authorpubmed-author:HammondE HEHlld:pubmed
pubmed-article:2113090pubmed:authorpubmed-author:WatsonF SFSlld:pubmed
pubmed-article:2113090pubmed:issnTypePrintlld:pubmed
pubmed-article:2113090pubmed:volume9lld:pubmed
pubmed-article:2113090pubmed:ownerNLMlld:pubmed
pubmed-article:2113090pubmed:authorsCompleteYlld:pubmed
pubmed-article:2113090pubmed:pagination236-8lld:pubmed
pubmed-article:2113090pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2113090pubmed:meshHeadingpubmed-meshheading:2113090-...lld:pubmed
pubmed-article:2113090pubmed:meshHeadingpubmed-meshheading:2113090-...lld:pubmed
pubmed-article:2113090pubmed:meshHeadingpubmed-meshheading:2113090-...lld:pubmed
pubmed-article:2113090pubmed:meshHeadingpubmed-meshheading:2113090-...lld:pubmed
pubmed-article:2113090pubmed:meshHeadingpubmed-meshheading:2113090-...lld:pubmed
pubmed-article:2113090pubmed:meshHeadingpubmed-meshheading:2113090-...lld:pubmed
pubmed-article:2113090pubmed:meshHeadingpubmed-meshheading:2113090-...lld:pubmed
pubmed-article:2113090pubmed:meshHeadingpubmed-meshheading:2113090-...lld:pubmed
pubmed-article:2113090pubmed:meshHeadingpubmed-meshheading:2113090-...lld:pubmed
pubmed-article:2113090pubmed:meshHeadingpubmed-meshheading:2113090-...lld:pubmed
pubmed-article:2113090pubmed:meshHeadingpubmed-meshheading:2113090-...lld:pubmed
pubmed-article:2113090pubmed:meshHeadingpubmed-meshheading:2113090-...lld:pubmed
pubmed-article:2113090pubmed:meshHeadingpubmed-meshheading:2113090-...lld:pubmed
pubmed-article:2113090pubmed:articleTitleFibrinoid necrosis of a temporal artery complicating the treatment of refractory cardiac allograft rejection with murine monoclonal CD3 antibody (OKT3).lld:pubmed
pubmed-article:2113090pubmed:affiliationDepartment of Internal Medicine, University of Utah Medical Center, Salt Lake City 84132.lld:pubmed
pubmed-article:2113090pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2113090pubmed:publicationTypeCase Reportslld:pubmed